Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Scandinavian Journal of Gastroenterology|September 6, 2016
Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 yearsBirgitte-Elise G Emken, Lars R Lundell, Lene Wallin, et al.
The British Journal of Surgery|August 6, 1998
Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. Nordic GORD Study Group. Gastro-oesophageal reflux diseaseL Lundell, J Dalenbäck, E Janatuinen, et al.
Scandinavian Journal of Gastroenterology|January 1, 1990
The benefit of colonoscopyE Brenna, K Skreden, H L Waldum, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trialL Lundell, N Havu, P Miettinen, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2012
Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibioticsSaira Khan, Anne Tøndervik, Håvard Sletta, et al.
Journal of the American College of Surgeons|February 28, 2001
Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux diseaseL Lundell, P Miettinen, H E Myrvold, et al.
Gastroenterology|July 27, 1999
Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study GroupL Lundell, P Miettinen, H E Myrvold, et al.
Gut|September 18, 2001
The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgeryH E Myrvold, L Lundell, P Miettinen, et al.
European Journal of Gastroenterology & Hepatology|August 25, 2000
Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study GroupL Lundell, P Miettinen, H E Myrvold, et al.
Acta Oncologica (Stockholm, Sweden)|February 27, 2009
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer GroupOlav Dahl, Øystein Fluge, Erik Carlsen, et al.
Pageof 16